| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-234 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G11-00 |
| filingDate |
1973-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1975-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9a2dc1726a7f02b435f72aa9623b7af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3c7fd3969c834bbadee25702dbc4f4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d7cc80072f1115da312c7950d91fc42 |
| publicationDate |
1975-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3904597-A |
| titleOfInvention |
Antibiotic derivatives |
| abstract |
Derivatives of kanamycin A and B have been prepared which possess substantially improved antibacterial activity. An example of such an agent is 1-(L-(-)- Beta -amino- Alpha hydroxypropionyl)-kanamycin B (IVa, BB-K122). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4065616-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4181797-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4160082-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4298727-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4104372-A |
| priorityDate |
1973-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |